Topoisomerase II alpha and TLE3 as predictive markers of response to anthracycline and taxane-containing regimens for neoadjuvant chemotherapy in breast cancer

Overview of attention for article published in OncoTargets and therapy, November 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 19 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

INTEGRATED ANALYSIS TO DETERMINE PROGNOSIS AFTER TREATMENT FOR PRIMARY BREAST CANCER

Application EP-3387443-A4

European Patent Office